MétaCan
Menu
← Back to cohort

Biological determinants of immune exclusion in non-small cell lung cancer: An analysis of the precision medicine BIP study.

2025· article· en· W4410795637 on OpenAlexaff
Jean‐Philippe Guégan, Florent Peyraud, Christophe Rey, Sophie Cousin, Sofiane Taleb, Natalie O. Karpinich, Jaegil Kim, Raouf El Cheikh, Sapna Yadavilli, Alban Bessede, Antoîne Italiano

Bibliographic record

VenueJournal of Clinical Oncology · 2025
Typearticle
Languageen
FieldMedicine
TopicCancer Immunotherapy and Biomarkers
Canadian institutionsGlaxoSmithKline (Canada)
Fundersnot available
KeywordsMedicineLung cancerImmune systemPrecision medicineCancerOncologyInternal medicineCancer researchImmunologyPathology

Abstract

fetched live from OpenAlex

2636 Background: Immune exclusion has been associated with resistance to immunotherapy in NSCLC. However, its biological determinants remain largely unknown. Instead of relying on preclinical models, high-throughput profiling of patient samples using spatial transcriptomics (ST) and multiplex immunofluorescence (m-IF) offers a powerful approach to dissect immune profiles and uncover key drivers of immune response and resistance. Methods: Tumor samples collected from NSCLC patients enrolled in the BIP precision medicine study (NCT02534649) prior to initiation of ICI therapy and divided into Discovery and Validation cohorts (n = 148 and 117, respectively). Response to treatment was assessed as per RECIST criteria. Multiplex immunohistochemistry (mIHC) with CD8 and panCK markers was used to classify tumors as desert, excluded or inflamed through pathologist assessment (PA) and image analysis ST using the NanoString GeoMx Whole Transcriptome Atlas compared gene expression profiles between inflamed and excluded tumors Spatially resolved T-cell receptor (TCR) profiling assessed clonal diversity and repertoire to evaluate T-cell functionality. m-IF was used for proteomic validation. Results: In both the training and validation cohorts, excluded tumors demonstrated lower objective response rates (ORR), progression-free survival (PFS), and overall survival (OS) compared to inflamed tumors (Table 1), independent of PD-L1 expression in multivariate analysis. ST identified marked overexpression of HLA-A/B (MHC class I) and CD74 (involved in MHC class II processing) in inflamed tumors versus excluded tumors, underscoring their crucial roles in antigen presentation. These results were validated by m-IF. Spatially resolved TCR profiling demonstrated higher Gini coefficients and lower Shannon entropy in excluded tumors, indicating a more oligoclonal TCR repertoire dominated by fewer T-cell clones. These findings suggest impaired antigen recognition and restricted T-cell diversity in excluded tumors. Conclusions: Our classification approach using mIHC and IA offers a practical, and clinically actionable biomarker for predicting response to ICI therapy. Immune exclusion, prevalent in NSCLC, is associated with resistance to ICI and characterized by reduced expression of key antigen presentation molecules such as HLA-A/B and CD74 and a restricted TCR repertoire highlighting the need for novel strategies to overcome this immune barrier. Phenotype Objective Response Rate (ORR) PFS (Median, Months) Discovery Inflamed(n=32) 58% 12.8 (95% CI: 6.16-NA) Excluded(n=65) 38.7% 4.1 (95% CI: 2.4-10.3) Desert(n=51) 20% 2.8 (95% CI: 1.9-6.9) Validation Inflamed (n=40) 57.5% 11.3 (95% CI: 4.6-NA) Excluded(n=30) 43.3% 6.1 (95% CI: 3.4-14.9) Desert(n=47) 31.9% 4.4 (95% CI: 2.3-7.2)

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.015

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0000.001
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.090
GPT teacher head0.488
Teacher spread0.398 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueJournal of Clinical Oncology→Same topicCancer Immunotherapy and Biomarkers→French-language works237,207→